作者
Eric S. Lightcap,Pengfei Yu,Stephen Grossman,Keli Song,Mithun Khattar,Kristina Xega,Xingyue He,James M. Gavin,Hisashi Imaichi,James Garnsey,Erik Koenig,Hongru Zhang,Zhen Lu,Pooja Shah,Yu Fu,Michael A. Milhollen,Beryl A. Hatton,Jessica Riceberg,Vaishali Shinde,Cong Li,James Minissale,Xiaofeng Yang,Dylan B. England,Richard A. Klinghoffer,Steven Langston,Katherine Galvin,Gary Shapiro,Sai Murali Krishna Pulukuri,Serge Y. Fuchs,Dennis Huszar
摘要
TAK-981, a first-in-class small-molecule SUMOylation inhibitor, activates type I interferon signaling to promote antitumor immune responses in mice.